Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Copaxone Subcutaneous Injection Syringe Special Drug Use-Result Investigation (All-Case Investigation) "Prevention of Relapse of Multiple Sclerosis"

NCT03209479 is registered in ClinicalTrials.gov with Teva Takeda Pharma Ltd. as lead sponsor.

NCT NCT03209479
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03209479 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Copaxone Subcutaneous Injection Syringe Special Drug Use-Result Investigation (All-Case Investigation) "Prevention of Relapse of Multiple Sclerosis"
Lead sponsor
Teva Takeda Pharma Ltd.
Phase
Observational
Overall status
Completed
Start date
November 24, 2015
Completion date
March 31, 2024
Enrollment
1,332 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis